Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Medicine

Background:

• Cardiovascular diseases (CVDs) are the leading global cause of mortality, with atherosclerosis being a primary driver.
• Current diagnostic and treatment methods for CVDs face limitations due to complex pathophysiology.
• Theranostic nanomaterials present a novel approach, integrating diagnostic and therapeutic functions.

Purpose of the Study:

• To review recent advancements in theranostic nanomaterials for cardiovascular disease diagnosis and treatment.
• To discuss various imaging modalities and therapeutic strategies employing theranostic nanoparticles.
• To identify current challenges and propose future research directions in the field.

Main Methods:

• Review of current literature on theranostic nanomaterials for CVDs.
• Discussion of diagnostic applications using techniques like MRI, PET, and CT.
• Exploration of therapeutic applications including photothermal ablation and drug delivery.

Main Results:

• Theranostic nanoparticles provide imaging contrast for multiple modalities (MRI, PET, CT).
• These nanoparticles can deliver targeted therapies, such as photothermal ablation and drug delivery.
• Widely used detection strategies include MRI, CT, near-infrared spectroscopy (NIR), and fluorescence.

Conclusions:

• Theranostic nanomaterials show significant promise for improving CVD diagnosis and treatment.
• Further research is needed to overcome current limitations and optimize their clinical application.
• The integration of diagnostics and therapeutics offers a powerful strategy for managing cardiovascular diseases.